CN1621055A - Pure Chinese traditional medicine for treating epilepsia - Google Patents

Pure Chinese traditional medicine for treating epilepsia Download PDF

Info

Publication number
CN1621055A
CN1621055A CN 200310105976 CN200310105976A CN1621055A CN 1621055 A CN1621055 A CN 1621055A CN 200310105976 CN200310105976 CN 200310105976 CN 200310105976 A CN200310105976 A CN 200310105976A CN 1621055 A CN1621055 A CN 1621055A
Authority
CN
China
Prior art keywords
chinese medicine
radix
rhizoma
magnetitum
scorpio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200310105976
Other languages
Chinese (zh)
Inventor
潘志安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200310105976 priority Critical patent/CN1621055A/en
Publication of CN1621055A publication Critical patent/CN1621055A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention is one kind of orally taken Chinese medicine for treating epilepsy. The Chinese medicine is prepared with Chinese medicinal materials gastrodia tuber, scorpion, tabasheer, bupleurum root and magnet; and into the Chinese medicinal materials, other three kinds including calamus, polygala root and arisaema with bile may be added. The Chinese medicine has obvious epilepsy treating effect and no toxic side effect.

Description

A kind of pure Chinese medicine for the treatment of epileptics
Affiliated technical field:
The present invention relates to a kind of Chinese patent medicine, the pure oral medicinal herb medicine in particularly a kind of tcm internal medicine field.
Background technology:
Epilepsy is a kind of syndrome with the feature of showing effect repeatedly of multiple brain diseases, it comprises the symptom and the Signs of one or more neural spiritual aspects, epilepsy is the paroxysmal brain dysfunction that the neuron over-discharge owing to brain one undue fever causes, clinical manifestation exists pathomorphism or Pathophysiology unusual in the brain for twitching or the sense consciousness behavior disorder, meaning.Western medicine can not effect a radical cure fully aspect treatment, can only disease controlling, and taking medicine for a long time has significant side effects to patient body.Serious harm patient's life security also causes certain burden for family.
Summary of the invention:
The objective of the invention is to design a kind of pure Chinese medicine for the treatment of epileptics, it has significant effect to the treatment epileptics, and has no side effect, and more the back is difficult for recurrence, double at all controlling.
Technical scheme of the present invention is: a kind of pure Chinese medicine for the treatment of epileptics, and it is characterized in that: it mainly comprises Rhizoma Gastrodiae, Scorpio, Concretio Silicea Bambusae, Radix Bupleuri, Magnetitum; Wherein Rhizoma Gastrodiae 20-30%, Scorpio 13.5-15%, Concretio Silicea Bambusae 13-20%, Radix Bupleuri 13.5-18%, Magnetitum 16-28%.
Rhizoma Gastrodiae 18-20%, Scorpio 8-13%, Concretio Silicea Bambusae 10-15%, Radix Bupleuri 8.5-15%, Magnetitum 12-18%, Rhizoma Acori Graminei 10-16%, Radix Polygalae 8.5-13%, Arisaema Cum Bile 8.5-15% in the described Chinese medicine.
Rhizoma Gastrodiae 15-20%, Scorpio 6-10%, Concretio Silicea Bambusae 8-13%, Radix Bupleuri 8-12%, Magnetitum 10-14%, Rhizoma Acori Graminei 9-13%, Radix Polygalae 8.5-12%, Arisaema Cum Bile 7.5-13.5%, Borax 2-3%, Fructus Schisandrae Chinensis 5-7% in the described Chinese medicine.
Rhizoma Gastrodiae 10-28%, Scorpio 5-8%, Concretio Silicea Bambusae 6-10%, Radix Bupleuri 5.5-11%, Magnetitum 10-12.5%, Rhizoma Acori Graminei 8-12%, Radix Polygalae 7-10.5%, Arisaema Cum Bile 6-11.5%, Borax 2-3%, Fructus Schisandrae Chinensis 4.5-6%, Poria 5.5-7%, Bombyx Batryticatus 5-7.5%, Rhizoma Pinelliae 5.5-9.5% in the described Chinese medicine.
Rhizoma Gastrodiae 5-15%, Scorpio 2-3%, Concretio Silicea Bambusae 3.5-5%, Radix Bupleuri 3.5-5%, Magnetitum 6.5-10%, Rhizoma Acori Graminei 3.5-5%, Radix Polygalae 3.5-6%, Arisaema Cum Bile 3-5%, Borax 1-1.5%, Fructus Schisandrae Chinensis 3-5%, Poria 6-7.5%, Bombyx Batryticatus 3-5%, Rhizoma Pinelliae 4-6.5%, Haematitum 6.5-10%, Radix Scutellariae 3.5-5%, Radix Glycyrrhizae 3-5% in the described Chinese medicine.
The content of described Chinese medicine is: Rhizoma Gastrodiae 5%, Scorpio 3%, Concretio Silicea Bambusae 5%, Radix Bupleuri 5%, Magnetitum 10%, Rhizoma Acori Graminei 5%, Radix Polygalae 6%, Arisaema Cum Bile 5%, Borax 1.5%, Fructus Schisandrae Chinensis 5%, Poria 8.5%, Bombyx Batryticatus 5%, Rhizoma Pinelliae 6.5%, Haematitum 10%, Radix Scutellariae 5%, Radix Glycyrrhizae 5%.
Described preparation method is: precentagewise after Chinese medicine Rhizoma Gastrodiae, Scorpio, Concretio Silicea Bambusae, Radix Bupleuri, Magnetitum, Rhizoma Acori Graminei, Radix Polygalae, Arisaema Cum Bile, Borax, Fructus Schisandrae Chinensis, Poria, Bombyx Batryticatus, Rhizoma Pinelliae, Haematitum, Radix Scutellariae, the Radix Glycyrrhizae infusion is weighed, be ground into fine powder, sterilize then, get final product by every 0.5g No. 3 capsules of packing into.
Characteristics of the present invention are: this Chinese medicine dispersing the stagnated live-QI to relieve the stagnation of QI, eliminate phlegm for resuscitation tranquillizing the mind by relieving convulsion.Selected
Chinese medicine, Radix Bupleuri: hot, sweet, be slightly cold, deliver rash, heat-clearing and toxic substances removing, ascending up spleen-Qi and Yang.
Radix Scutellariae: bitter, cold, heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive.
Bombyx Batryticatus: salty, hot, flat, endogenous wind stopping relieving convulsion, wind-expelling pain-stopping, detoxicating and resolving stagnation of pathogens.
Rhizoma Pinelliae: suffering, temperature, drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.
Rhizoma Acori Graminei: suffering, temperature, resuscitation inducing and mind tranquilizing, removing dampness to restore normal function of the stomach.Radix Polygalae: suffering, hardship, tepor, mind tranquilizing and the heart calming, go that expectorant is had one's ideas straightened out, subduing inflammation.
Concretio Silicea Bambusae: sweet, cold, removing heat-phlegm, arresting convulsion clears away heart-fire.
The Rhizoma Atractylodis Macrocephalae: sweet, warm, air making-up and spleen enlivening, dampness diuretic, hidroschesis are antiabortive.
Arisaema Cum Bile: bitter, salty, cold, removing heat-phlegm, dispelling wind and relieving convulsion.
Magnetitum: hot, salty, cold, subduing hyperactive YANG to ease mental disorders, hearing-improing and eyesight improving, helping inspiration to relieve asthma.
Haematitum: bitter, cold, suppressing the hyperactive liver and subsiding YANG, sending down the abnormal ascending QI hemostasis.
Poria: sweet, light, flat, promoting diuresis to eliminate damp pathogen, spleen-benefiting mind-tranquilizing.
Scorpio: hot, flat, endogenous wind stopping relieving convulsion, detoxicating and resolving stagnation of pathogens, removing obstruction in the collateral to relieve pain.
Fructus Schisandrae Chinensis: acid temperature, the nourishing kidney of astringing the lung, the arresting sweating that promotes the production of body fluid, arresting seminal emission, mind tranquilizing and the heart calming.
Rhizoma Gastrodiae: sweet, flat, endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG.
Borax: sweet, salty, cold, heat-clearing and toxic substances removing, removing heat from the lung and dissipating phlegm.
Radix Glycyrrhizae: invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, relieving spasm to stop pain, the mitigation property of medicine.
The present invention will be further described below in conjunction with embodiment
Prescription is by Rhizoma Gastrodiae 5%, Scorpio 3%, Concretio Silicea Bambusae 5%, Radix Bupleuri 5%, Magnetitum 10%, Rhizoma Acori Graminei 5%, Radix Polygalae 6%, Arisaema Cum Bile 5%, Borax 1.5%, Fructus Schisandrae Chinensis 5%, Poria 8.5%, Bombyx Batryticatus 5%, Rhizoma Pinelliae 6.5%, Haematitum 10%, Radix Scutellariae 5%, Radix Glycyrrhizae 5%.Form.Its technology is earlier the Rhizoma Gastrodiae in the above-mentioned prescription, Scorpio, Concretio Silicea Bambusae, Radix Bupleuri, Magnetitum, Rhizoma Acori Graminei, Radix Polygalae, Arisaema Cum Bile, Borax, Fructus Schisandrae Chinensis, Poria, Bombyx Batryticatus, Rhizoma Pinelliae, Haematitum, Radix Scutellariae, Radix Glycyrrhizae precentagewise to be weighed, cross 300 mesh sieves, screen with dustpan, trailing plants basket, the medicine that filters out, last mill, be ground into smalls, sterilize then, get final product by every 0.5g No. 3 capsules of packing into.
Instructions of taking of the present invention is to take five, every day three times at every turn.
Prove by a large amount of clinical trials: 60 men are arranged, and 50 woman suffer from epileptics, the effective percentage 98% that takes this medicine, and cure rate 66%, patient's medication can be cured 1-2 the course of treatment, and more the back is difficult for recurrence, nontoxic secondary untoward reaction, curative effect is obvious, and is easy to use.

Claims (7)

1, a kind of pure Chinese medicine for the treatment of epileptics, it is characterized in that: it mainly comprises Rhizoma Gastrodiae, Scorpio, Concretio Silicea Bambusae, Radix Bupleuri, Magnetitum; Wherein Rhizoma Gastrodiae 20-30%, Scorpio 13.5-15%, Concretio Silicea Bambusae 13-20%, Radix Bupleuri 13.5-18%, Magnetitum 16-28%.
2, a kind of pure Chinese medicine for the treatment of epileptics according to claim 1 is characterized in that: Rhizoma Gastrodiae 18-20%, Scorpio 8-13%, Concretio Silicea Bambusae 10-15%, Radix Bupleuri 8.5-15%, Magnetitum 12-18%, Rhizoma Acori Graminei 10-16%, Radix Polygalae 8.5-13%, Arisaema Cum Bile 8.5-15% in the described Chinese medicine.
3, a kind of pure Chinese medicine for the treatment of epileptics according to claim 1 is characterized in that: Rhizoma Gastrodiae 15-20%, Scorpio 6-10%, Concretio Silicea Bambusae 8-13%, Radix Bupleuri 8-12%, Magnetitum 10-14%, Rhizoma Acori Graminei 9-13%, Radix Polygalae 8.5-12%, Arisaema Cum Bile 7.5-13.5%, Borax 2-3%, Fructus Schisandrae Chinensis 5-7% in the described Chinese medicine.
4, a kind of pure Chinese medicine for the treatment of epileptics according to claim 1 is characterized in that: Rhizoma Gastrodiae 10-28%, Scorpio 5-8%, Concretio Silicea Bambusae 6-10%, Radix Bupleuri 5.5-11%, Magnetitum 10-12.5%, Rhizoma Acori Graminei 8-12%, Radix Polygalae 7-10.5%, Arisaema Cum Bile 6-11.5%, Borax 2-3%, Fructus Schisandrae Chinensis 4.5-6%, Poria 5.5-7%, Bombyx Batryticatus 5-7.5%, Rhizoma Pinelliae 5.5-9.5% in the described Chinese medicine.
5, a kind of pure Chinese medicine for the treatment of epileptics according to claim 1 is characterized in that: Rhizoma Gastrodiae 5-15%, Scorpio 2-3%, Concretio Silicea Bambusae 3.5-5%, Radix Bupleuri 3.5-5%, Magnetitum 6.5-10%, Rhizoma Acori Graminei 3.5-5%, Radix Polygalae 3.5-6%, Arisaema Cum Bile 3-5%, Borax 1-1.5%, Fructus Schisandrae Chinensis 3-5%, Poria 6-7.5%, Bombyx Batryticatus 3-5%, Rhizoma Pinelliae 4-6.5%, Haematitum 6.5-10%, Radix Scutellariae 3.5-5%, Radix Glycyrrhizae 3-5% in the described Chinese medicine.
6, a kind of pure Chinese medicine for the treatment of epileptics according to claim 1, it is characterized in that: the content of described Chinese medicine is: Rhizoma Gastrodiae 5%, Scorpio 3%, Concretio Silicea Bambusae 5%, Radix Bupleuri 5%, Magnetitum 10%, Rhizoma Acori Graminei 5%, Radix Polygalae 6%, Arisaema Cum Bile 5%, Borax 1.5%, Fructus Schisandrae Chinensis 5%, Poria 8.5%, Bombyx Batryticatus 5%, Rhizoma Pinelliae 6.5%, Haematitum 10%, Radix Scutellariae 5%, Radix Glycyrrhizae 5%.
7, a kind of pure Chinese medicine for the treatment of epileptics according to claim 1, it is characterized in that: described preparation method is: precentagewise after Chinese medicine Rhizoma Gastrodiae, Scorpio, Concretio Silicea Bambusae, Radix Bupleuri, Magnetitum, Rhizoma Acori Graminei, Radix Polygalae, Arisaema Cum Bile, Borax, Fructus Schisandrae Chinensis, Poria, Bombyx Batryticatus, Rhizoma Pinelliae, Haematitum, Radix Scutellariae, the Radix Glycyrrhizae infusion is weighed, be ground into fine powder, sterilize then, get final product by every 0.5g No. 3 capsules of packing into.
CN 200310105976 2003-11-27 2003-11-27 Pure Chinese traditional medicine for treating epilepsia Pending CN1621055A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200310105976 CN1621055A (en) 2003-11-27 2003-11-27 Pure Chinese traditional medicine for treating epilepsia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200310105976 CN1621055A (en) 2003-11-27 2003-11-27 Pure Chinese traditional medicine for treating epilepsia

Publications (1)

Publication Number Publication Date
CN1621055A true CN1621055A (en) 2005-06-01

Family

ID=34757488

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200310105976 Pending CN1621055A (en) 2003-11-27 2003-11-27 Pure Chinese traditional medicine for treating epilepsia

Country Status (1)

Country Link
CN (1) CN1621055A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102114149A (en) * 2011-02-15 2011-07-06 黑龙江康元神经专科医院有限责任公司 Chinese medicine preparation for treating epilepsy
CN104398859A (en) * 2014-12-09 2015-03-11 王淑廷 Traditional Chinese medicinal pills for treating epilepsy
CN104940710A (en) * 2015-07-23 2015-09-30 彭雄彬 Traditional Chinese medicine Kangning composition comprising soncretio silicea bambusae for treating epilepsy, and preparation method thereof
CN105709171A (en) * 2015-02-05 2016-06-29 王学权 Traditional Chinese medicinal pills for treating epilepsy

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102114149A (en) * 2011-02-15 2011-07-06 黑龙江康元神经专科医院有限责任公司 Chinese medicine preparation for treating epilepsy
CN102114149B (en) * 2011-02-15 2013-03-13 黑龙江康元神经专科医院有限责任公司 Chinese medicine preparation for treating epilepsy
CN104398859A (en) * 2014-12-09 2015-03-11 王淑廷 Traditional Chinese medicinal pills for treating epilepsy
CN105709171A (en) * 2015-02-05 2016-06-29 王学权 Traditional Chinese medicinal pills for treating epilepsy
CN104940710A (en) * 2015-07-23 2015-09-30 彭雄彬 Traditional Chinese medicine Kangning composition comprising soncretio silicea bambusae for treating epilepsy, and preparation method thereof
CN104940710B (en) * 2015-07-23 2019-03-05 彭雄彬 Healthy and free from worry Chinese medicine composition of tabasheer epilepsy and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1201793C (en) Medicine composition for treatment of cough and asthma and preparation thereof
CN101972418A (en) Health-care tea for preventing and treating common cold
CN101264233A (en) Chinese medicinal composition for treating lobar pneumonia and preparation thereof
CN1621055A (en) Pure Chinese traditional medicine for treating epilepsia
CN111249396A (en) Traditional Chinese medicine for treating chronic gastritis and preparation method of micronized particles thereof
CN1872332A (en) Medication for treating rhinitis, and preparation method
CN104857477A (en) Traditional Chinese medicine for treating bronchial asthma
CN1202851C (en) Medicine for treating children's cold and its prepn process
CN100342894C (en) A Chinese medicine for treating liver disease
CN1107511C (en) Specific medicine for treating common cold
CN1069053C (en) Oral medicine for treating phlegm-heat cough
CN1350868A (en) Medicine for preventing and treating cold and its preparing process
CN101856488A (en) Chinese medicament for treating tracheitis
CN101085201A (en) Medicine for treating common cold and preparation method thereof
CN102526462B (en) Traditional Chinese medicine composition for treating tinnitus
CN101073656A (en) Pear antitussive syrup with antasthmatic and lung-moistening functions
CN1178682C (en) Angiocardiopathy treating traditional Chinese medicine
CN1468629A (en) Traditional Chinese medicine composition for treating wind-heat type common cold and preparation method thereof
CN1141947C (en) Syrup for treating cough and asthma and its prodn. tech.
CN108619274B (en) Traditional Chinese medicine composition for treating recurrent respiratory tract infection of children
CN1730071A (en) Purple perilla capsule and process for preparing the same
CN106389768A (en) Medicine composition for treating nasal diseases and preparation method thereof
CN1225266A (en) Liquid medicine for treating cold
CN102688406B (en) Houttuynia cordata traditional Chinese medicine decoction for treating cough and preparation method
CN1234395C (en) Medicinal tea of infused in boiling water and its production method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication